ArticleLangenbeck's archives of surgery2026
Long-term results (> 12 years) of surgical treatment of perihilar cholangiocarcinoma: Application of a modified Nagoya approach at a western center.
Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo analyze the results of a modified Nagoya approach in perihilar cholangiocarcinoma at a western center.
methodsThe first author trained for one year at Nagoya University. The records of the 53 patients who underwent major hepatobiliary resection between 2001 and 2012 were reviewed. All fundamental principles were strictly applied with following modifications: hepatoduodenal ligament dissection limited to the level cranial to the gastroduodenal artery; 8a-p lymph nodes removed only if macroscopically positive; adjuvant radiotherapy, chemoradiotherapy (CRT) and CRT followed by chemotherapy in selected patients starting in 2007,2009 and 2011 respectively. The results were compared with the 2021 international benchmark values.
resultsTwenty-seven patients were men; median (range) age was 54 (29-74). Percutaneous biliary drainage was performed in 45 patients (85%) and portal vein embolization in 8 (15%). Portal vein resection was required in 10 patients (19%). The 90-day mortality was 4% (2/53). Perihepatic fluid infection without an obvious biliary leak was the most frequent complication (42%). The frequencies of liver failure B-C and bile leak were 8% and 12% respectively. The calculated 1,3,5 and 10 -year survival rates were 87%,62%, 41% and 25% respectively. Thirteen patients (25%) survived longer than 10 years: seven had T1 and six had T2a tumors; none had a poorly differentiated tumor, positive surgical margins or lymph node metastasis.
conclusionsThe modified Nagoya approach yielded outcomes similar to 25th percentile values for 90-day mortality, postoperative liver failure B-C and bile leak and benchmark values for 5-year overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.